tag haematology 
Pharmaceutical Technology
MAY 2, 2023
In contrast to ICIs, which are utilised against solid tumours, cell therapies and bispecifics have been transformational in the haematological cancer settings, with approvals across a range of leukaemias and lymphomas. Cost-related unmet needs also scored highly.
The Pharma Data
AUGUST 18, 2020
The investigational therapy has obviously caught the eye of BMS, and it was confirmed that the company intends to exercise its newly bought rights to push the drug forward in oncology and haematology.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 23, 2022
price tag of $475,000 when it was first launched in 2017 – and it becomes apparent that these may not be desirable treatment options for every patient and in every setting. Add to this the considerable cost of these medications – the first approved CAR-T, Novartis’ Kymriah (tisagenlecleucel), had a U.S. Professional reception of the findings.
Drug Discovery World
JUNE 14, 2023
For example, CAR Ts have accomplished awesome successes in haematologic malignancies, and people are also trying to apply these technologies to solid tumours – but successes remain pending. We have now our lead product in a Phase I/II study, which is a HER-2 directed tag T cell product for patients with HER-2 positive solid tumours.
pharmaphorum
OCTOBER 4, 2022
The Biobank was launched in 2020, with an initial aim of enrolling at least 1,000 patients with locally advanced or metastatic solid tumours and haematologic malignancies undergoing standard of care therapy. Building a bank. The entire process takes place in the physician’s office, alongside a clinician.
Expert insights. Personalized for you.
130 
Let's personalize your content